China Universal Asset Management Company’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$325K Sell
10,783
-4,326
-29% -$140K 0.02% 304
2025
Q4
$524K Buy
15,109
+8,088
+115% +$286K 0.04% 256
2025
Q3
$255K Sell
7,021
-961
-12% -$32.6K 0.02% 313
2025
Q2
$250K Buy
7,982
+35
+0.4% +$1.09K 0.02% 292
2025
Q1
$236K Sell
7,947
-446
-5% -$13.4K 0.02% 297
2024
Q4
$248K Buy
8,393
+960
+13% +$30.4K 0.02% 312
2024
Q3
$231K Buy
7,433
+3,053
+70% +$111K 0.03% 289
2024
Q2
$148K Sell
4,380
-2,241
-34% -$114K 0.02% 271
2024
Q1
$430K Buy
6,621
+2,721
+70% +$187K 0.05% 197
2023
Q4
$266K Buy
3,900
+3,064
+367% +$159K 0.05% 182
2023
Q3
$43.4K Buy
836
+426
+104% +$25.2K 0.01% 237
2023
Q2
$24.6K Buy
410
+6
+1% +$342 0.01% 247
2023
Q1
$20K Buy
404
+142
+54% +$7.99K 0.01% 220
2022
Q4
$15K Buy
+262
New +$14.7K 0.01% 198

Other funds holding IMCR

China Universal Asset Management Company's IMCR Position: Q1 2026 in Review

China Universal Asset Management Company reduced its Immunocore (IMCR) stake by 29% in Q1 2026, selling an estimated $140K and leaving 10,783 shares worth $325K. The position accounts for 0.02% of the portfolio, ranked #304.

China Universal Asset Management Company first reported a position in IMCR in Q4 2022 and has held it in 14 quarters since. The position peaked at $524K in Q4 2025. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • China Universal Asset Management Company held 10,783 shares of Immunocore worth $325K as of Q1 2026.
  • China Universal Asset Management Company sold 4,326 Immunocore shares in Q1 2026, an estimated $140K.
  • Immunocore made up 0.02% of China Universal Asset Management Company's portfolio in Q1 2026, its #304 holding.
  • China Universal Asset Management Company first reported a position in Immunocore in Q4 2022 and has held it in 14 quarters since.
  • China Universal Asset Management Company's Immunocore position peaked at $524K in Q4 2025.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.